Comparison between Laxyo IPO and Manipal Health Enterprises IPO.
Laxyo IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Manipal Health Enterprises IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Laxyo IPO is up to ₹150.00 Cr whereas the issue size of the Manipal Health Enterprises IPO is up to ₹0.00 Cr. The final issue price of Laxyo IPO is and of Manipal Health Enterprises IPO is .
| Laxyo IPO | Manipal Health Enterprises IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹150.00 Cr | up to ₹8,000.00 Cr |
| OFS Issue Size | 0 shares | 4,32,27,668 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹150.00 Cr | up to ₹0.00 Cr |
Laxyo IPO opens on , while Manipal Health Enterprises IPO opens on . The closing date of Laxyo IPO and Manipal Health Enterprises IPO is , and , respectively.
Laxyo IPO P/E ratio is , as compared to Manipal Health Enterprises IPO P/E ratio of .
| Laxyo IPO | Manipal Health Enterprises IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Proforma Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 81.42 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 19.36 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 19.89 | 26.98 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.88 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 19.36 | 18.16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Laxyo IPO Retail Individual Investors (RII) are offered 0 shares while in Manipal Health Enterprises IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Laxyo IPO and 0 shares in Manipal Health Enterprises IPO.
| Laxyo IPO | Manipal Health Enterprises IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Laxyo IPO subscribed in total, whereas Manipal Health Enterprises IPO subscribed .
